Standardized CBD Composition With Balanced Fatty Acids for Skin Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing compositions of CBD from hemp plants struggle with inconsistency in phytochemical levels due to fluctuating outdoor cultivation conditions, making it difficult to produce a consistently effective combination of active ingredients for treating skin disorders and inflammation.
Innovation Solution
A composition comprising at least 0.1% CBD, a balanced ratio of omega-3 and omega-6 fatty acids, and a sterol, optionally with vitamin E and antioxidants, providing a standardized formulation for treating skin disorders and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If CBD is extracted from outdoor cultivated hemp plants, then the composition contains natural phytochemicals with therapeutic benefits, but the levels of active ingredients vary due to temperature and weather fluctuations
Solution Approach 1:
The patent extracts only the CBD component from the hemp plant through isolation processes, separating it from other variable phytochemicals. This extraction approach removes the source of inconsistency while retaining the therapeutic active ingredient, solving the reliability problem by eliminating environmental variability.
Solution Approach 2:
The patent changes the cultivation parameters by moving from outdoor to controlled indoor environments with regulated temperature, humidity, and light conditions. This parameter control ensures consistent CBD production across batches, directly addressing the reliability issue caused by weather fluctuations.
2Manufacturing precision
If traditional outdoor cultivation practices are used, then the production process is simple and cost-effective, but the phytochemical composition lacks consistency and repeatability
Solution Approach 1:
The patent implements preliminary action by establishing controlled cultivation conditions and standardized extraction protocols before production begins. This pre-planning and preparation of controlled environments ensures that the desired phytochemical composition is achieved consistently from the start, rather than attempting to correct variations after cultivation.
Solution Approach 2:
The patent changes cultivation parameters from uncontrolled outdoor conditions to controlled indoor parameters including temperature, humidity, and light cycles. This parameter standardization enables repeatable phytochemical composition while the use of standardized extraction protocols further ensures manufacturing precision.
3Reliability
If hemp extracts are used to treat skin disorders and inflammation, then therapeutic benefits are achieved through endocannabinoid system modulation, but the variable composition makes it difficult to ensure consistent efficacy
Solution Approach 1:
The patent extracts and isolates CBD as the primary active ingredient, removing it from the variable whole-plant extract matrix. This isolation allows for precise dosing and consistent therapeutic efficacy, as the quantity and purity of the active ingredient can be controlled and standardized in the final formulation.
Solution Approach 2:
The patent creates a composite formulation combining isolated CBD with other standardized ingredients such as fatty acids and sterols. This composite approach ensures consistent efficacy by combining multiple standardized components in defined ratios, rather than relying on the variable composition of raw hemp extracts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively treats skin disorders and inflammation by modulating the endocannabinoid system, supporting skin and immune health with a balanced ratio of fatty acids and sterols, enhancing bioavailability and therapeutic efficacy.
Implementation Method 1
CBD is reported to have a variety of biological activities due to its activity on the endocannabinoid system, in particular activity at the cannabinoid type 2 receptor (CB2)
Implementation Method 2
at least about 40% by weight of a fatty acid component comprising a balanced ratio of an omega-3 fatty acid and an omega-6 fatty acid
Implementation Method 3
a vitamin E compound; and an antioxidant
Data Source
AI summary
The application provides a composition comprising cannadibiol, a fatty acid component comprising a balanced amount of omega-3 and omega-6 fatty acids, and a sterol and optionally a vitamin E compound. The composition has been shown to be well tolerated and supportive when administered to subjects suffering from or at risk of developing a skin disorder and/or an inflammatory condition, such as atopic dermatitis. Also disclosed are methods of supporting the immune system and skin health of a subject involving administration of the compositions.